Abstract

The NS-21 was well tolerated and effective for the maintenance of skin moisture; however, there was no statistically significant reduction in the risk of acute radiation dermatitis (ARD) in head and neck cancer (HNC) patients undergoing radiotherapy (RT) or concurrent chemoradiation therapy (CCRT) when compared with HNC patients in the control group.

Authors

Hsiu-Ling Chou

Author Details

Hsiu-Ling Chou, PhD, Department of Nursing, Oriental Institute of Technology, New Taipei City and School of Nursing, National Yang-Ming University, Taipei, Department of Nursing, Far Eastern Memorial Hospital, New Taipei City, Taiwan

Sigma Membership

Non-member

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Head and Neck Cancer, NS-21, Skin Moisture

Conference Name

31st International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Virtual Event

Conference Year

2020

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (347 kB)

Share

COinS
 

Prophylactic NS-21 maintains the skin moisture in head and neck cancer patients undergoing chemoradiation therapy

Virtual Event

The NS-21 was well tolerated and effective for the maintenance of skin moisture; however, there was no statistically significant reduction in the risk of acute radiation dermatitis (ARD) in head and neck cancer (HNC) patients undergoing radiotherapy (RT) or concurrent chemoradiation therapy (CCRT) when compared with HNC patients in the control group.